# PIRFENIDONE
> **ANDA212077** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2022-08-01
## Drug
- **FDA Application Number:** ANDA212077
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PIRFENIDONE
- **Generic name:** PIRFENIDONE
- **Active ingredients:** PIRFENIDONE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SCIEGEN PHARMS
- **Manufacturer:** ScieGen Pharmaceuticals, Inc.
- **First approval:** 2022-08-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212077)
---
*MORVS · CC0 1.0*